Skip to content

Double Incision and Comparison of the outcomes of Minimal Incision technique in treatment of carpal tunnel syndrome

Double Incision and Comparison of the outcomes of Minimal Incision technique in treatment of carpal tunnel syndrome

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20160508027797N5
Enrollment
50
Registered
2019-03-11
Start date
2018-11-18
Completion date
Unknown
Last updated
2019-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carpal tunnel syndrome. Carpal tunnel syndrome

Interventions

Intervention 1: Intervention group: Minimal Incision Surgery. Intervention 2: Control group: Double Incision Surgery.

Sponsors

Babol University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with carpal tunnel syndrome

Exclusion criteria

Exclusion criteria: Failure to follow the patient after surgery Carpal tunnel syndrome recurs after CTR surgery Patients whose symptoms are severe, such as trauma, fracture, bleeding, and damage during surgery.

Design outcomes

Primary

MeasureTime frame
Pain. Timepoint: Before surgery and six month of surgery. Method of measurement: Visual Analogue Scale.;Paresthesia. Timepoint: Before surgery and six month of surgery. Method of measurement: Based on patient response.;Numbness. Timepoint: Before surgery and six month of surgery. Method of measurement: Based on boston form.;Weakness. Timepoint: Before surgery and six month of surgery. Method of measurement: Based on boston form.

Secondary

MeasureTime frame
Return to daily activities. Timepoint: Before surgery and six month of surgery. Method of measurement: Based on boston form.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Ilia Roshani

Babol University of Medical Sciences

iliaroshani@yahoo.com+98 11 3225 6285

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026